Wealthcare Advisory Partners LLC Sangamo Therapeutics, Inc Transaction History

Wealthcare Advisory Partners LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $652,500 - $952,500	-50,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$13.9 - $19.8 $556,000 - $792,000	40,000 Added 400.0%	50,000 $710,000
Q1 2018 May 15, 2018	BUY	$16.7 - $26.35 $167,000 - $263,500	10,000 New	10,000 $190,000

138

100M

35.5K

65.8K

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $50.1M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.